Emily Le

Emily Le is a technology commercialization and business development professional with experience working across academia, the biopharmaceutical industry, and executive leadership. Before joining the Stanford Office of Technology Licensing (OTL), she led Business Development and Licensing activities for Research at The Jackson Laboratory (JAX), partnering with faculty to advance and commercialize innovative technologies. Earlier at JAX, she was a member of the Strategic Insights and Innovation team, where she evaluated emerging opportunities, conducted market and competitive analyses, and developed strategic recommendations. Emily earned her Ph.D. in Chemistry, where she developed nanoparticle-based biosensors for cancer diagnostics.